glp-1 medication semaglutide Lower doses of the agonist as effective as higher ones, Danish study finds Diabetes Patients Also Struggle to

Description

The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies

Assemble your supplies: Medication Syringe Medication Log Container for syringe and needle disposal Sterile 2x2-inch gauze pad Alcohol pads LOCATING INJECTION SITES Subcutaneous injections can be given in the arms, legs, or abdomen

Listed effects of GLP-1 include: 1) reduced glucagon secretion from the liver (thereby slowing down the release of glucose, or blood sugar, into the bloodstream during periods of fasting or reduced food intake), 2) increased insulin production, 3) decreased appetite, and 4) decreased intestinal motility (causing food to move slower through the digestive system, thereby further improving blood sugar and reducing appetite)

A., Matuskey D., Pittman B., et al., Testing the Effects of the GLP1 Receptor Agonist Exenatide on Cocaine SelfAdministration and Subjective Responses in Humans With Cocaine Use Disorder, Drug and Alcohol Dependence 221 (2021): 108614, 10.1016/j.drugalcdep.2021.108614